Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 50
Summary
- Conditions
- Depressive Disorder, Major
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03429075
- Collaborators
- Alexander Mosely Charitable Trust
- Investigators
- Principal Investigator: David J Nutt, Medicine Imperial College London
Get Well Soon